Pfizer CEO Albert Bourla joins The Exchange to discuss new developments with his company’s Covid vaccine, one of the two mRNA vaccines approved for emergency use in the U.S. The company is reporting new data about waning immunity and protection…
Pfizer CEO Albert Bourla joins The Exchange to discuss new developments with his company’s Covid vaccine, one of the two mRNA vaccines approved for emergency use in the U.S. The company is reporting new data about waning immunity and protection…
Study: Immune system ‘remembers’ coronavirus for at least six months Please subscribe: ——————- #virus, #covid19 ——————- Source:
Most people who have recovered from Covid-19 have similar levels of immunity against future infection to those who received a coronavirus vaccine, a study by Public Health England found, offering early hope against fears of a short-lived immunity spurred on…